Join Verpora’s Omar Ali at ACCESS EU ’26 as he co-leads an interactive workshop exploring the future of cell and gene therapy commercialisation and the ACCESS Framework for sustainable market access.

Join Verpora’s Omar Ali at the 10th Annual VirtueInsight PRMA Philadelphia Conference, where he delivers a keynote, leads an innovative contracting roundtable, and moderates a panel on the future of market access strategy.

Verpora is proud to sponsor and attend UK Oncology Forum 2026, sharing research and insights that support better patient outcomes, access, and NHS efficiency.

Verpora’s Head of Payers, Omar Ali, will speak at Navlin’s Pharma Pricing & Access Innovation Conference 2025 in Basel—joining global sessions on payer strategy, access, and value assessment.

The BHBIA Annual Conference 2026 brings two days of debates, workshops and insight on pharma, data and decision-making. Explore four workstreams, key NHS and AI themes, and a new Rising Star complimentary pass.

Omar Ali presents insights from IPAY26 and IPAY27 CMS drug price negotiations at Model N Rainmaker, focused on payer impact and pricing strategy.

Omar Ali joins World Orphan Drug Congress Europe 2025 to explore how payers are reacting to the rising cost of rare disease innovation—and what comes next for sustainable access.

Omar Ali (Head of Payers, Verpora) joins a panel of market access pioneers, to share insights into the latest innovations in RWE, learn best practices for leveraging data to improve outcomes, and explore emerging technologies in data analytics.

Join Verpora at the Pharma Pricing & Market Access Congress 2025 in Philadelphia, where Omar Ali and Drake Reiter lead a workshop on value-based contracting and share first-hand lessons from CMS drug price negotiations.

Verpora’s Adam Buckler joins senior leaders from Takeda, Sanofi, and ZS at ACCESS EU 2025 to explore the future capabilities shaping successful market access teams across Europe and the U.S.

Omar Ali speaks in Dubai on innovative pricing models that help healthcare systems manage the cost of life-saving therapies without compromising access.

Omar Ali joins global oncology leaders in Dubai to explore how value-based agreements and creative contracting are making next-gen cancer therapies more accessible.

Verpora’s Head of Payers, Omar Ali, will speak at Navlin’s Pharma Pricing & Access Innovation Conference 2025 in Basel—joining global sessions on payer strategy, access, and value assessment.

Verpora will be participating in Rainmaker 2025, Model N’s annual conference bringing together pharmaceutical and med-tech leaders to discuss pricing, contracting, and revenue management in a rapidly evolving market.

Verpora is attending Pricing & Contracting USA 2025 in Philadelphia to engage in conversations around IRA implementation, IPAY strategies, and value-based contracting. Get in touch to meet us there.

Verpora is a Gold Sponsor at the BHBIA Annual Conference 2025. Meet our VSTx team to discuss NHS data access, priority gaps, and real-world evidence insights.

Join Verpora’s Omar Ali at MAPR Europe 2025 as he explores global challenges in funding innovation, value-based agreements, and real-world access models for high-cost therapies.

Join Omar Ali (Verpora) and Ross Margulies (Manatt Health) at PPIC as they break down key lessons from IRA negotiations—what worked, what didn’t, and how manufacturers may prepare for future rounds.

Omar Ali joins AMCP 2024’s rich agenda of educational sessions, pre-conference programs, and unparalleled networking opportunities.

Presented by Verpora’s Omar Ali, alongside Jamie Foley, Global Director, Value-based Contracting & Innovation, MSD, this workshop opens the Pandora’s Box into a phenomenal repository of US & Global innovative contracts between payers, governments & pharmaceutical companies and medtech.

Join Verpora at EPP Life Sciences Pricing Forum 2024 - the must-attend conference for pricing directors and executives, and all of those involved in pricing, market access and reimbursement for the Pharmaceutical, MedTech and Biotech industries.